Why the study?
Does stent-based delivery of sirolimus reduce neointimal formation in a porcine coronary model?
Does stent-based delivery of sirolimus reduce neointimal formation in a porcine coronary model?
Answers are grounded in this paper and cite their sources.
Stent-based delivery of sirolimus via a nonerodable polymer matrix is feasible and effectively reduces neointimal hyperplasia in a preclinical porcine model.
Stent-based delivery of SRL via a nonerodable polymer matrix is feasible and effectively reduces in-stent neointimal hyperplasia by inhibiting cellular proliferation.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2001) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: